Therapeutic potential of ischaemic preconditioning.
Edwards
R J
RJ
Department of Cardiology, KCL, St Thomas' Hospital, London SE1.
Saurin
A T
AT
Rakhit
R D
RD
Marber
M S
MS
D000241:Adenosine / Q000627:therapeutic use; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000789:Angina, Unstable / Q000628:therapy*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D006801:Humans; D019157:Ischemic Preconditioning, Myocardial; D009203:Myocardial Infarction / Q000628:therapy*; D009206:Myocardium / Q000166:cytology; D011493:Protein Kinase C / Q000627:therapeutic use; D018047:Receptors, Purinergic P1 / Q000187:drug effects / Q000378:metabolism
D000889:Anti-Arrhythmia Agents; D018047:Receptors, Purinergic P1; D000255:Adenosine Triphosphate; D011493:Protein Kinase C; D000241:Adenosine